Today announced the pricing of an underwritten public offering of 55,555,556 shares of its common stock and accompanying warrants to purchase up to an aggregate of 55,555,556 shares of its common stock.

The combined public offering price of each share of common stock and accompanying warrant to purchase one share is $0.99.

The accompanying warrants have an exercise price of $1.10 per share, will become exercisable immediately and will expire five years from the date of issuance.

Outlook Therapeutics also granted the underwriters an option for a period of 30 days to purchase up to 8,333,333 additional shares of its common stock and/or warrants to purchase up to 8,333,333 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions.

SOURCE:

https://ir.outlooktherapeutics.com/node/12896/pdf

This document has 74 pages, see the link below.

SOURCE:

https://ir.outlooktherapeutics.com/static-files/d80f7d82-de74-4aba-a07a-31ae66200682

SOURCE:

https://ir.outlooktherapeutics.com/node/12881/pdf

About

Complex problems have shaped my career.

I partner with executives and organizations to turn complex challenges into actionable plans, scalable operations, and meaningful business outcomes.

Whether leading organizational change during a major acquisition, building operational frameworks from the ground up, or guiding executive leaders through competing priorities, I've built my career on bringing clarity, building trust, creating alignment, and delivering meaningful results.

Over the past 20+ years, I've worked alongside executive leaders to lead strategic initiatives, strengthen operations, and help organizations navigate change with confidence.

My career has taken me across biotechnology, technology, telecommunications, manufacturing, and research organizations—including Pfizer (formerly Seagen), Amazon, and privately held companies.

I'm at my best when there isn't a playbook.

I thrive in ambiguity, asking the right questions, building structure where it's needed, and turning complex challenges into actionable results. Whether the priority is improving operations, leading cross-functional initiatives, supporting executive decision-making, or guiding teams through change, the best results come from creating clarity, building alignment, and earning trust.

Strong partnerships are built on trust, follow-through, and a shared commitment to meaningful outcomes. That's the value I bring to every executive partnership and the standard I bring to every organization I support.

https://preview.redd.it/mg6d6uudycih1.png?width=936&format=png&auto=webp&s=c7a9122831c142e3865ef2f37ba30b9f5608fce7

https://preview.redd.it/3t9tq0vfycih1.png?width=936&format=png&auto=webp&s=3f05a2a787f2c1b6f6627010d6d0fd85ac2f2d3b

https://preview.redd.it/ebvqp9zhycih1.png?width=936&format=png&auto=webp&s=ef572c93e1847f5f683cbfd7b68a54b37da27b45

https://preview.redd.it/vkiwxb3kycih1.png?width=936&format=png&auto=webp&s=15ef66753384714b5a652190a3ac3191144caea8

https://preview.redd.it/3ewcothmycih1.png?width=936&format=png&auto=webp&s=60f0e4281515569cf88ceca12cbbec6ef22a4b0a

SOURCE:

StockTwits + Linkedin

ABOUT OUTLOOK THERAPEUTICS

Outlook Therapeutics (Nasdaq: OTLK) is a commercial-stage biopharmaceutical company redefining the standard of care in retinal disease. In the United States, our lead product has received FDA approval, making it the first and only FDA-approved ophthalmic formulation of its kind for the treatment of wet AMD, and we are preparing for US commercial launch. Our lead product is also the first ophthalmic formulation of its kind to receive Marketing Authorization from the European Commission and the UK MHRA for the treatment of wet age-related macular degeneration (wet AMD), and has launched across Germany, Austria, and the UK. Driven by the stories of the patients we serve, we are united with the vision-care community around a single goal: a future where everyone with retinal disease can envision a brighter world.

THE OPPORTUNITY

Reports to: Country Lead UK

Location: UK, field based

Direct reports: no

This is a rare ground-floor moment at a company hitting its commercial inflection point. As a lean, fast-moving organization, we offer scope and ownership that larger companies can’t: your work is visible, your decisions matter, and you’ll help build the function rather than simply maintain it. You’ll partner directly with senior leadership and see a clear line between what you do and patients gaining access to a new treatment option.

Our lead product is commercially available in the UK, and you will be the face of Outlook Therapeutics to the retinal specialists, NHS Trusts, and hospital pharmacy teams who determine patient access to it. You will own growing our footprint across new and existing accounts.

WHAT YOU'LL DO

Account Strategy & Relationship Management

• Own the commercial relationship with a defined portfolio of NHS Trusts, retinal consultants, and hospital pharmacy leads across the UK.
• Build multi-level engagement plans that map key decision-makers and influencers within each account.
• Serve as the primary point of contact for accounts, coordinating all commercial touchpoints.

Access & Commercial Execution

• Defend and expand formulary position across existing accounts while opening access in new ones.
• Navigate NHS tender, procurement, and ICB funding pathways to grow volume and deepen penetration.
• Own account-level growth targets, translating brand strategy into local account plans.

Cross-Functional Collaboration

• Partner with medical affairs, marketing, and market access to align account plans with scientific and commercial priorities.
• Feed field insights into brand and launch planning to sharpen UK go-to-market execution.
• Coordinate with field medical on scientific engagement to support appropriate product use.

Market Intelligence & Reporting

• Monitor the UK retinal disease competitive landscape, NHS policy shifts, and account dynamics.
• Maintain accurate CRM records and deliver timely account and pipeline reporting to leadership

WHAT YOU'LL BRING

Required

• Bachelor's degree, or equivalent professional experience.
• 5+ years of key account management or specialty pharmaceutical sales experience within the UK NHS environment.
• Working knowledge of NHS funding, procurement, and formulary processes (e.g., ICB, hospital pharmacy, tender routes).
• Demonstrated track record building and managing relationships with hospital consultants and specialist clinical teams.
• Full, valid UK driving license and willingness to travel regularly across the assigned territory.

Preferred

• Experience in ophthalmology, retina, or another hospital-administered specialty biologic.
• Experience growing an early-stage specialty or biologic brand post-launch in the UK market.
• Familiarity with MHRA-approved product commercialization and NHS market access frameworks.

OUR COMMITMENT

Outlook Therapeutics is an equal opportunity employer. We are committed to building an inclusive environment where every team member can do their best work, and we consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.

SOURCE:

LINKEDIN

ABOUT OUTLOOK THERAPEUTICS

Outlook Therapeutics (Nasdaq: OTLK) is a commercial-stage biopharmaceutical company redefining the standard of care in retinal disease. In the United States, our lead product has received FDA approval, making it the first and only FDA-approved ophthalmic formulation of its kind for the treatment of wet AMD, and we are preparing for US commercial launch. Our lead product is also the first ophthalmic formulation of its kind to receive Marketing Authorization from the European Commission and the UK MHRA for the treatment of wet age-related macular degeneration (wet AMD), and has launched across Germany, Austria, and the UK. Driven by the stories of the patients we serve, we are united with the vision-care community around a single goal: a future where everyone with retinal disease can envision a brighter world.

THE OPPORTUNITY

Reports to: Medical Affairs Lead Europe

Location: UK, field based - needs to be willing to travel

Direct reports: no

This is a rare ground-floor moment at a company hitting its commercial inflection point. As a lean, fast-moving organization, we offer scope and ownership that larger companies can’t: your work is visible, your decisions matter, and you’ll help build the function rather than simply maintain it. You’ll partner directly with senior leadership and see a clear line between what you do and patients gaining access to a new treatment option.

This role blends field-based Medical Science Liaison engagement with broader Medical Affairs strategy — as we grow, you'll help shape the scope of the function itself, not just execute within it.

WHAT YOU'LL DO

Medical Affairs & Field Medical Engagement

• Support development and execution of Medical Affairs strategy and initiatives
• Build and maintain relationships with healthcare professionals, investigators, and key opinion leaders
• Lead scientific exchange with external stakeholders on company products, clinical data, and disease state information
• Support medical education activities and scientific communication efforts, including advisory boards, scientific meetings, and webinars
• Represent Medical Affairs at scientific congresses, meetings, and educational events

Real-World Evidence & Medical Insights

• Support real-world evidence initiatives and data collection activities
• Contribute to analysis and communication of scientific and clinical insights
• Gather and communicate field insights to internal stakeholders
• Identify emerging trends, opportunities, and unmet needs within the therapeutic area

Cross-Functional Collaboration

• Partner closely with Commercial, Market Access, Regulatory Affairs, and Clinical Development
• Provide scientific support for launch readiness and commercialization activities
• Participate in cross-functional planning and strategic initiatives

Compliance & Medical Review

• Support medical review and approval processes as assigned
• Ensure scientific accuracy and compliance of medical and promotional materials
• Uphold adherence to applicable regulatory and compliance requirements

Organizational Growth

• Contribute to development of scalable Medical Affairs processes and capabilities
• Support onboarding and functional guidance for future team members as the organization scales
• Participate in organizational planning and continuous improvement initiatives

WHAT YOU'LL BRING

Required

• Experience within Medical Affairs, Field Medical, Clinical, or related healthcare environments
• Strong scientific communication and relationship-management skills with healthcare professionals, investigators, and key opinion leaders
• Prior experience in ophthalmology or a related specialty therapeutic area
• Demonstrated ability to work cross-functionally in a dynamic, evolving organization
• Ability to travel as business needs require
• Full, valid UK driving license and willingness to travel regularly across the assigned territory.

Preferred

• Advanced scientific, medical, or healthcare degree (e.g., PharmD, PhD, MD, or equivalent clinical/scientific credential)
• Experience supporting evidence generation, RWE initiatives, or medical communications at a small or growth-stage biopharma company

OUR COMMITMENT

Outlook Therapeutics is an equal opportunity employer. We are committed to building an inclusive environment where every team member can do their best work, and we consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.

SOURCE:

LINKEDIN

About

As a strategic business partner, executive leader, and attorney, I align legal, privacy, compliance, risk, and human capital strategy to enable the business growth and innovation, improve performance, create shared vision across teams, and resolve complex organizational challenges. It is my goal to enable the business to execute their goals in a compliant way.

Throughout my career, I have
- Partnered with the C-suite and across functions to navigate risk and amplify opportunity in highly regulated environments.
- Been repeatedly trusted to guide businesses, rally teams, and foster clarity through restructuring, growth, ambiguity, and crisis.
- Addressed operational and technical deficiencies, implemented controls, built strong privacy and legal practices, and navigated acquisitions and integrations.
- Demonstrated strong understanding of domestic and international laws, regulations, and business perspectives.
- Leveraged a deep understanding of data to enable business strategy.
- Strategically led negotiations that have resulted in significant cost savings and market expansions.

I am a passionate leader committed to operating with integrity and honesty when advising leadership, guiding teams, and influencing organizational cultures. With a mission-focused drive, I aim to foster diversity, inclusiveness, and belonging and serve as an influential contributor to environmental, sustainable, and ethical impacts. Through years of global work for two of the world’s largest companies as well as other market leading companies, I have successfully managed and formed connections with cross functional teams across the world and have a strong appreciation for diversity of thought as a catalyst for sustainable progress.

SOURCE:

LINKEDIN

SOURCE:

https://ir.outlooktherapeutics.com/node/12871/pdf